The fat mass and obesity-associated (FTO) and melanocortin-4 receptor (MC4R) genes have been implicated in the pathophysiology of obesity. However, their regulatory behavior in human gastric tissue and association with […]
Sleeve gastrectomy (SG) is the most commonly performed metabolic surgery for obesity but is associated with long-term recurrent weight gain (RWG) and recurrence of comorbidities. Ring-augmented sleeve gastrectomy (RASG) has […]
There are no prediction models of stent outcomes for leaks after metabolic and bariatric surgery (MBS). The current study developed an artificial intelligence–based model to predict post-MBS stent failure. Prospectively […]
Reflux-related symptoms, upper endoscopy (UE), and histopathology findings comprise a triad of changes of gastro-esophageal reflux disease (GERD) following one anastomosis gastric bypass (OAGB). However, the evolution and interplay between […]
One anastomosis gastric bypass (OAGB) as a metabolic and bariatric surgery (MBS) procedure is endorsed by bariatric societies and federations, ranks third among the MBS family, and delivers promising outcomes […]
Obstructive Sleep Apnea (OSA) represents a significant global health challenge, closely linked to obesity and a heightened risk for cardiovascular and metabolic disorders. Continuous Positive Airway Pressure (CPAP) remains the […]
Roux-en-Y gastric bypass (RYGB) is one of the most effective bariatric procedures worldwide, providing both restrictive and malabsorptive benefits. However, marked heterogeneity exists globally in pouch construction, limb configuration, mesenteric […]
Obstructed defecation syndrome (ODS) is a prevalent pelvic floor disorder, often impairing patients’ quality of life. Noninvasive therapies, including posterior tibial nerve stimulation (PTNS), have been explored as alternative treatments. […]
The ethical practice of medicine has always existed within a dialectic of action and restraint, where healing often entails “controlled harm.” Nowhere is this paradox more pronounced than in metabolic […]
Carotid intima-media thickness (CIMT) is a widely recognized marker of subclinical atherosclerosis. Emerging evidence suggests that long non-coding RNAs (lncRNAs), such as ANRIL, may contribute to the development of vascular […]
